{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:32:37Z","timestamp":1791419557988,"version":"4.3.3"},"reference-count":154,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.nbd.2011.08.023","type":"journal-article","created":{"date-parts":[[2011,8,27]],"date-time":"2011-08-27T04:48:01Z","timestamp":1314420481000},"page":"202-211","source":"Crossref","is-referenced-by-count":23,"title":["Viral-mediated overexpression of mutant huntingtin to model HD in various species"],"prefix":"10.1016","volume":"48","author":[{"given":"Marta","family":"Ruiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"D\u00e9glon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2011.08.023_bb0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2202-5-4","article-title":"Efficient delivery of Cre-recombinase to neurons in vivo and stable transduction of neurons using adeno-associated and lentiviral vectors","volume":"5","author":"Ahmed","year":"2004","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.nbd.2011.08.023_bb0010","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1093\/hmg\/ddn106","article-title":"Striatal and nigral pathology in a lentiviral rat model of Machado\u2013Joseph disease","volume":"17","author":"Alves","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.08.023_bb0015","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1523\/JNEUROSCI.5409-05.2006","article-title":"CA150 expression delays striatal cell death in overexpression and knock-in conditions for mutant huntingtin neurotoxicity","volume":"26","author":"Arango","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.08.023_bb0020","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/gt.2009.135","article-title":"Integrase-defective lentiviral vectors: progress and applications","volume":"17","author":"Banasik","year":"2010","journal-title":"Gene Ther."},{"key":"10.1016\/j.nbd.2011.08.023_bb0025","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.wco.0000084223.82329.bb","article-title":"Experimental therapeutics in Huntington's disease: are models useful for therapeutic trials?","volume":"16","author":"Bates","year":"2003","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.nbd.2011.08.023_bb0030","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","article-title":"Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid","volume":"13","author":"Beal","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.08.023_bb0035","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1091\/mbc.E05-07-0607","article-title":"Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin","volume":"17","author":"Benchoua","year":"2006","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.nbd.2011.08.023_bb0040","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/hmg\/ddn033","article-title":"Dopamine determines the vulnerability of striatal neurons to the N-terminal fragment of mutant huntingtin through the regulation of mitochondrial complex II","volume":"17","author":"Benchoua","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.08.023_bb0045","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1128\/JVI.71.9.6641-6649.1997","article-title":"Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector","volume":"71","author":"Blomer","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.nbd.2011.08.023_bb0050","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1523\/JNEUROSCI.14-03-00985.1994","article-title":"Expression of mRNAs encoding ARPP-16\/19, ARPP-21, and DARPP-32 in human brain tissue","volume":"14","author":"Brene","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.08.023_bb0055","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1046\/j.1460-9568.2000.00040.x","article-title":"Regulation of GluR2 promoter activity by neurotrophic factors via a neuron-restrictive silencer element","volume":"12","author":"Brene","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2011.08.023_bb0060","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.neuroscience.2005.11.057","article-title":"Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain","volume":"138","author":"Broekman","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2011.08.023_bb0065","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1073\/pnas.92.15.7105","article-title":"Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates","volume":"92","author":"Brouillet","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.08.023_bb0070","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0301-0082(99)00005-2","article-title":"Replicating Huntington's disease phenotype in experimental animals","volume":"59","author":"Brouillet","year":"1999","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2011.08.023_bb0080","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ymthe.2004.05.024","article-title":"Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system","volume":"10","author":"Burger","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2011.08.023_bb0085","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.expneurol.2010.10.016","article-title":"Pseudotype-dependent lentiviral transduction of astrocytes or neurons in the rat substantia nigra","volume":"228","author":"Cannon","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.08.023_bb0090","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nrn1806","article-title":"Normal huntingtin function: an alternative approach to Huntington's disease","volume":"6","author":"Cattaneo","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2011.08.023_bb0095","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ymthe.2005.11.015","article-title":"Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain","volume":"13","author":"Cearley","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2011.08.023_bb0100","doi-asserted-by":"crossref","first-page":"9928","DOI":"10.1523\/JNEUROSCI.2185-07.2007","article-title":"A single injection of an adeno-associated virus vector into nuclei with divergent connections results in widespread vector distribution in the brain and global correction of a neurogenetic disease","volume":"27","author":"Cearley","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.08.023_bb0105","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0006-8993(98)00169-3","article-title":"Recombinant adeno-associated virus vector: use for transgene expression and anterograde tract tracing in the CNS","volume":"793","author":"Chamberlin","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2011.08.023_bb0110","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ymeth.2009.05.007","article-title":"Generation of transgenic monkeys with human inherited genetic disease","volume":"49","author":"Chan","year":"2009","journal-title":"Methods"},{"key":"10.1016\/j.nbd.2011.08.023_bb0115","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1006\/mthe.2000.0219","article-title":"Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors","volume":"2","author":"Chao","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2011.08.023_bb0120","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/mds.870110605","article-title":"Striatal interneurons in Huntington's disease: selective increase in the density of calretinin-immunoreactive medium-sized neurons","volume":"11","author":"Cicchetti","year":"1996","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.08.023_bb0125","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1460-9568.2005.03985.x","article-title":"Akt is altered in an animal model of Huntington's disease and in patients","volume":"21","author":"Colin","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2011.08.023_bb0130","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/glia.20795","article-title":"Engineered lentiviral vector targeting astrocytes in vivo","volume":"57","author":"Colin","year":"2009","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2011.08.023_bb0135","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/hmg\/7.5.783","article-title":"Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture","volume":"7","author":"Cooper","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.08.023_bb0140","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neuron.2010.12.035","article-title":"Huntington's disease: can mice lead the way to treatment?","volume":"69","author":"Crook","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2011.08.023_bb0145","first-page":"179","article-title":"Behavioral and psychiatric symptoms associated with Huntington's disease","volume":"65","author":"Cummings","year":"1995","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.nbd.2011.08.023_bb0150","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1073\/pnas.97.7.3428","article-title":"Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system","volume":"97","author":"Davidson","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.08.023_bb0155","first-page":"554","article-title":"Lentiviral vectors in clinical trials: current status","volume":"11","author":"D'Costa","year":"2009","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.nbd.2011.08.023_bb0160","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1523\/JNEUROSCI.22-09-03473.2002","article-title":"Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein length","volume":"22","author":"de Almeida","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.08.023_bb0165","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/978-3-642-56114-6_10","article-title":"Lentiviruses as vectors for CNS diseases","volume":"261","author":"D\u00e9glon","year":"2002","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.nbd.2011.08.023_bb0170","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/jgm.707","article-title":"Viral vectors as tools to model and treat neurodegenerative disorders","volume":"7","author":"D\u00e9glon","year":"2005","journal-title":"J. Gene Med."},{"key":"10.1016\/j.nbd.2011.08.023_bb0175","doi-asserted-by":"crossref","first-page":"17204","DOI":"10.1073\/pnas.0708285104","article-title":"Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits","volume":"104","author":"DiFiglia","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.08.023_bb0180","doi-asserted-by":"crossref","first-page":"e4637","DOI":"10.1371\/journal.pone.0004637","article-title":"Normal aging modulates the neurotoxicity of mutant huntingtin","volume":"4","author":"Diguet","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2011.08.023_bb0185","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/mt.2009.216","article-title":"Differential transduction following basal ganglia administration of distinct pseudotyped AAV capsid serotypes in nonhuman primates","volume":"18","author":"Dodiya","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2011.08.023_bb0190","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.21569","article-title":"Sustained effects of nonallele-specific Huntingtin silencing","volume":"65","author":"Drouet","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.08.023_bb0195","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1212\/01.wnl.0000312381.29287.ff","article-title":"Results from a phase I safety trial of hAADC gene therapy for Parkinson disease","volume":"70","author":"Eberling","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.08.023_bb0200","doi-asserted-by":"crossref","first-page":"5978","DOI":"10.1523\/JNEUROSCI.0302-06.2006","article-title":"Ciliary neurotrophic factor activates astrocytes, redistributes their glutamate transporters GLAST and GLT-1 to raft microdomains, and improves glutamate handling in vivo","volume":"26","author":"Escartin","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.08.023_bb0205","doi-asserted-by":"crossref","first-page":"7094","DOI":"10.1523\/JNEUROSCI.0174-07.2007","article-title":"Activation of astrocytes by CNTF induces metabolic plasticity and increases resistance to metabolic insults","volume":"27","author":"Escartin","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.08.023_bb0210","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1093\/hmg\/ddq212","article-title":"In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects","volume":"19","author":"Faideau","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.08.023_bb0215","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1089\/104303401750195935","article-title":"A new-generation stable inducible packaging cell line for lentiviral vectors","volume":"12","author":"Farson","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.nbd.2011.08.023_bb0220","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1073\/pnas.89.5.1636","article-title":"Expression of nerve growth factor in vivo from a defective herpes simplex virus 1 vector prevents effects of axotomy on sympathetic ganglia","volume":"89","author":"Federoff","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.08.023_bb0225","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1126\/science.2931802","article-title":"Selective sparing of a class of striatal neurons in Huntington's disease","volume":"230","author":"Ferrante","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.nbd.2011.08.023_bb0230","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0006-8993(87)90694-9","article-title":"Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease","volume":"411","author":"Ferrante","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2011.08.023_bb0235","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/mt.2008.50","article-title":"AAV vector-mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic rat model of Huntington's disease","volume":"16","author":"Franich","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2011.08.023_bb0240","doi-asserted-by":"crossref","first-page":"9302","DOI":"10.1073\/pnas.91.20.9302","article-title":"Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter","volume":"91","author":"Furth","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.08.023_bb0245","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1126\/science.2843986","article-title":"A defective HSV-1 vector expresses Escherichia coli beta-galactosidase in cultured peripheral neurons","volume":"241","author":"Geller","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.nbd.2011.08.023_bb0250","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1006\/mthe.2002.0588","article-title":"Adenoviral-mediated, high-level, cell-specific transgene expression: a SYN1-WPRE cassette mediates increased transgene expression with no loss of neuron specificity","volume":"5","author":"Glover","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2011.08.023_bb0255","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/1531-8249(200101)49:1<29::AID-ANA7>3.0.CO;2-B","article-title":"Quantitative neuropathological changes in presymptomatic Huntington's disease","volume":"49","author":"Gomez-Tortosa","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.08.023_bb0260","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1126\/science.1167093","article-title":"Optical deconstruction of parkinsonian neural circuitry","volume":"324","author":"Gradinaru","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.nbd.2011.08.023_bb0265","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice","volume":"28","author":"Gray","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.08.023_bb0270","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","article-title":"Unified Huntington's Disease Rating Scale: reliability and consistency. Huntington Study Group","volume":"11","author":"Group, H. S.","year":"1996","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.08.023_bb0275","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group","volume":"72","author":"Group, T. H. s. D. C. R.","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2011.08.023_bb0280","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0014-4886(90)90014-J","article-title":"A primate model of Huntington's disease: behavioral and anatomical studies of unilateral excitotoxic lesions of the caudate\u2013putamen in the baboon","volume":"108","author":"Hantraye","year":"1990","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.08.023_bb0285","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1073\/pnas.89.9.4187","article-title":"Intrastriatal transplantation of cross-species fetal striatal cells reduces abnormal movements in a primate model of Huntington disease","volume":"89","author":"Hantraye","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.08.023_bb0290","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1073\/pnas.0501507102","article-title":"RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model","volume":"102","author":"Harper","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.08.023_bb0295","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","article-title":"A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration","volume":"23","author":"Hodgson","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2011.08.023_bb0300","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/sj.mt.6300367","article-title":"Efficient retrograde neuronal transduction utilizing self-complementary AAV1","volume":"16","author":"Hollis","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2011.08.023_bb0305","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00001756-199412300-00014","article-title":"Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease","volume":"6","author":"Horellou","year":"1994","journal-title":"Neuroreport"},{"key":"10.1016\/j.nbd.2011.08.023_bb0310","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/jgm.1150","article-title":"Inducing huntingtin inclusion formation in primary neuronal cell culture and in vivo by high-capacity adenoviral vectors expressing truncated and full-length huntingtin with polyglutamine expansion","volume":"10","author":"Huang","year":"2008","journal-title":"J. Gene Med."},{"key":"10.1016\/j.nbd.2011.08.023_bb0315","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cmet.2011.02.013","article-title":"Mutant huntingtin causes metabolic imbalance by disruption of hypothalamic neurocircuits","volume":"13","author":"Hult","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.nbd.2011.08.023_bb0320","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0896-6273(00)80573-5","article-title":"Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons","volume":"21","author":"Jackson","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2011.08.023_bb0325","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/jnr.10719","article-title":"Targeted transgene expression in rat brain using lentiviral vectors","volume":"73","author":"Jakobsson","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2011.08.023_bb0330","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.0953-816X.2003.03147.x","article-title":"Lesion-dependent regulation of transgene expression in the rat brain using a human glial fibrillary acidic protein-lentiviral vector","volume":"19","author":"Jakobsson","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2011.08.023_bb0335","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ng1094-148","article-title":"Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain","volume":"8","author":"Kaplitt","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2011.08.023_bb0340","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/S0140-6736(07)60982-9","article-title":"Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial","volume":"369","author":"Kaplitt","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2011.08.023_bb0345","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1089\/hum.2007.082","article-title":"Efficient gene transfer via retrograde transport in rodent and primate brains using a human immunodeficiency virus type 1-based vector pseudotyped with rabies virus glycoprotein","volume":"18","author":"Kato","year":"2007","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.nbd.2011.08.023_bb0350","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1089\/hum.2009.179","article-title":"A lentiviral strategy for highly efficient retrograde gene transfer by pseudotyping with fusion envelope glycoprotein","volume":"22","author":"Kato","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.nbd.2011.08.023_bb0355","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/83324","article-title":"Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics","volume":"7","author":"Kay","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2011.08.023_bb0360","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0166-2236(03)00164-4","article-title":"Modeling CNS neurodegeneration by overexpression of disease-causing proteins using viral vectors","volume":"26","author":"Kirik","year":"2003","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2011.08.023_bb0365","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1073\/pnas.0536383100","article-title":"Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson's disease","volume":"100","author":"Kirik","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.08.023_bb0370","doi-asserted-by":"crossref","first-page":"10933","DOI":"10.1073\/pnas.93.20.10933","article-title":"Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice","volume":"93","author":"Kistner","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.08.023_bb0375","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1006\/mthe.2000.0103","article-title":"A stable system for the high-titer production of multiply attenuated lentiviral vectors","volume":"2","author":"Klages","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2011.08.023_bb0380","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ana.410080402","article-title":"Presymptomatic and early detection in Huntington's disease","volume":"8","author":"Klawans","year":"1980","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.08.023_bb0385","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.expneurol.2009.12.009","article-title":"Adeno-associated viral vector serotypes 1 and 5 targeted to the neonatal rat and pig striatum induce widespread transgene expression in the forebrain","volume":"222","author":"Kornum","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.08.023_bb0390","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0167-0115(93)90028-7","article-title":"Substance P and substance P receptor histochemistry in human neurodegenerative diseases","volume":"46","author":"Kowall","year":"1993","journal-title":"Regul. Pept."},{"key":"10.1016\/j.nbd.2011.08.023_bb0395","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/hmg\/ddm133","article-title":"Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage","volume":"16","author":"Kuhn","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.08.023_bb0400","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1399-0004.2004.00241.x","article-title":"A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length","volume":"65","author":"Langbehn","year":"2004","journal-title":"Clin. Genet."},{"key":"10.1016\/j.nbd.2011.08.023_bb0405","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1750-1326-2-11","article-title":"Novel rat Alzheimer's disease models based on AAV-mediated gene transfer to selectively increase hippocampal Abeta levels","volume":"2","author":"Lawlor","year":"2007","journal-title":"Mol. Neurodegener."},{"issue":"Pt 5","key":"10.1016\/j.nbd.2011.08.023_bb0410","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/brain\/119.5.1633","article-title":"Executive and mnemonic functions in early Huntington's disease","volume":"119","author":"Lawrence","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.08.023_bb0415","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1126\/science.8382374","article-title":"An adenovirus vector for gene transfer into neurons and glia in the brain","volume":"259","author":"Le Gal La Salle","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.nbd.2011.08.023_bb0420","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.0.CO;2-F","article-title":"Enhanced sensitivity to N-methyl-d-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease","volume":"58","author":"Levine","year":"1999","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2011.08.023_bb0425","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.phrs.2009.10.002","article-title":"Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS","volume":"61","author":"Lim","year":"2010","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.nbd.2011.08.023_bb0430","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/hmg\/10.2.137","article-title":"Neurological abnormalities in a knock-in mouse model of Huntington's disease","volume":"10","author":"Lin","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.08.023_bb0435","doi-asserted-by":"crossref","first-page":"28873","DOI":"10.1074\/jbc.273.44.28873","article-title":"Expression of polyglutamine-expanded Huntingtin activates the SEK1-JNK pathway and induces apoptosis in a hippocampal neuronal cell line","volume":"273","author":"Liu","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.08.023_bb0440","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/nn1988","article-title":"Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease","volume":"10","author":"Lobsiger","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2011.08.023_bb0445","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.expneurol.2009.03.004","article-title":"A majority of Huntington's disease patients may be treatable by individualized allele-specific RNA interference","volume":"217","author":"Lombardi","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.08.023_bb0450","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2174\/156652308786847996","article-title":"Applications of lentiviral vectors for biology and gene therapy of neurological disorders","volume":"8","author":"Lundberg","year":"2008","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.nbd.2011.08.023_bb0455","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/hmg\/7.9.1355","article-title":"A cellular model that recapitulates major pathogenic steps of Huntington's disease","volume":"7","author":"Lunkes","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.08.023_bb0460","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1097-2765(02)00602-0","article-title":"Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions","volume":"10","author":"Lunkes","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.nbd.2011.08.023_bb0465","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ymthe.2005.11.009","article-title":"Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders","volume":"13","author":"Mandel","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2011.08.023_bb0470","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.expneurol.2011.03.013","article-title":"The development of flexible lentiviral vectors for gene transfer in the CNS","volume":"229","author":"Manfredsson","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.08.023_bb0475","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2011.08.023_bb0480","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1089\/hum.2005.16.17","article-title":"Regulatory considerations for novel gene therapy products: a review of the process leading to the first clinical lentiviral vector","volume":"16","author":"Manilla","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.nbd.2011.08.023_bb0485","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S1474-4422(10)70254-4","article-title":"Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial","volume":"9","author":"Marks","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2011.08.023_bb0490","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/hmg\/ddr148","article-title":"Mitogen- and stress-activated protein kinase 1-induced neuroprotection in Huntington's disease: role on chromatin remodeling at the PGC-1-alpha promoter","volume":"20","author":"Martin","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.08.023_bb0495","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1126\/science.274.5293.1678","article-title":"Control of memory formation through regulated expression of a CaMKII transgene","volume":"274","author":"Mayford","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.nbd.2011.08.023_bb0500","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/hmg\/10.19.2109","article-title":"Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery","volume":"10","author":"Mazarakis","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.08.023_bb0505","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.1073\/pnas.0801775105","article-title":"Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi","volume":"105","author":"McBride","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.08.023_bb0510","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0006-8993(95)01488-8","article-title":"Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector","volume":"713","author":"McCown","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2011.08.023_bb0515","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/263517a0","article-title":"Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids","volume":"263","author":"McGeer","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2011.08.023_bb0520","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1602\/neurorx.2.3.465","article-title":"Knock-in mouse models of Huntington's disease","volume":"2","author":"Menalled","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.nbd.2011.08.023_bb0525","doi-asserted-by":"crossref","first-page":"8266","DOI":"10.1523\/JNEUROSCI.22-18-08266.2002","article-title":"Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington's disease knock-in mice","volume":"22","author":"Menalled","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.08.023_bb0530","doi-asserted-by":"crossref","first-page":"7195","DOI":"10.1073\/pnas.1231012100","article-title":"Allele-specific silencing of dominant disease genes","volume":"100","author":"Miller","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.08.023_bb0535","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1089\/10430340050015220","article-title":"Restoration of cognitive and motor functions by ciliary neurotrophic factor in a primate model of Huntington's disease","volume":"11","author":"Mittoux","year":"2000","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.nbd.2011.08.023_bb0540","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1172\/JCI45364","article-title":"The importance of integrating basic and clinical research toward the development of new therapies for Huntington disease","volume":"121","author":"Munoz-Sanjuan","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2011.08.023_bb0545","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/ng1093-168","article-title":"De novo expansion of a (CAG)n repeat in sporadic Huntington's disease","volume":"5","author":"Myers","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2011.08.023_bb0550","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.272.5259.263","article-title":"In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector","volume":"272","author":"Naldini","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.nbd.2011.08.023_bb0555","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1523\/JNEUROSCI.16-09-03019.1996","article-title":"Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease","volume":"16","author":"Palfi","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.08.023_bb0560","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/sj.mt.6300185","article-title":"Expression of mutated huntingtin fragment in the putamen is sufficient to produce abnormal movement in non-human primates","volume":"15","author":"Palfi","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2011.08.023_bb0565","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1523\/JNEUROSCI.3706-05.2006","article-title":"Inhibition of calcineurin by FK506 protects against polyglutamine-huntingtin toxicity through an increase of huntingtin phosphorylation at S421","volume":"26","author":"Pardo","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.08.023_bb0570","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.cell.2008.07.041","article-title":"Disease-specific induced pluripotent stem cells","volume":"134","author":"Park","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2011.08.023_bb0575","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.1128\/JVI.77.12.7034-7040.2003","volume":"77","author":"Passini","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.nbd.2011.08.023_bb0580","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/mt.sj.6300141","article-title":"Neuroprotection by Hsp104 and Hsp27 in lentiviral-based rat models of Huntington's disease","volume":"15","author":"Perrin","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2011.08.023_bb0585","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.expneurol.2008.10.008","article-title":"Implication of the JNK pathway in a rat model of Huntington's disease","volume":"215","author":"Perrin","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.08.023_bb0590","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/hmg\/10.12.1243","article-title":"Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration","volume":"10","author":"Petersen","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.08.023_bb0595","doi-asserted-by":"crossref","first-page":"11450","DOI":"10.1073\/pnas.201415498","article-title":"Delivery of the Cre recombinase by a self-deleting lentiviral vector: efficient gene targeting in vivo","volume":"98","author":"Pfeifer","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.08.023_bb0600","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.cub.2009.03.030","article-title":"Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington's disease patients","volume":"19","author":"Pfister","year":"2009","journal-title":"Curr. Biol."},{"key":"10.1016\/j.nbd.2011.08.023_bb0605","doi-asserted-by":"crossref","first-page":"16589","DOI":"10.1073\/pnas.1009158107","article-title":"A regulatory toolbox of MiniPromoters to drive selective expression in the brain","volume":"107","author":"Portales-Casamar","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.08.023_bb0610","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1093\/hmg\/ddg305","article-title":"Early and reversible neuropathology induced by tetracycline-regulated lentiviral overexpression of mutant huntingtin in rat striatum","volume":"12","author":"Regulier","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.08.023_bb0615","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ymthe.2005.05.006","article-title":"Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6\/1 Huntington's disease transgenic mice","volume":"12","author":"Rodriguez-Lebron","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2011.08.023_bb0620","first-page":"137","article-title":"Behavioral and morphological comparison of two nonhuman primate models of Huntington's disease","volume":"50","author":"Roitberg","year":"2002","journal-title":"Neurosurgery"},{"key":"10.1016\/j.nbd.2011.08.023_bb0625","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2011.08.023_bb0630","doi-asserted-by":"crossref","first-page":"9723","DOI":"10.1523\/JNEUROSCI.3044-08.2008","article-title":"Dysregulation of gene expression in primary neuron models of Huntington's disease shows that polyglutamine-related effects on the striatal transcriptome may not be dependent on brain circuitry","volume":"28","author":"Runne","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.08.023_bb0635","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0092-8674(00)81782-1","article-title":"Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions","volume":"95","author":"Saudou","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2011.08.023_bb0640","doi-asserted-by":"crossref","first-page":"5762","DOI":"10.1523\/JNEUROSCI.23-13-05762.2003","article-title":"Focal deletion of the adenosine A1 receptor in adult mice using an adeno-associated viral vector","volume":"23","author":"Scammell","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.08.023_bb0645","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2174\/156652308786848049","article-title":"Clinical application of lentiviral vectors\u2014concepts and practice","volume":"8","author":"Schambach","year":"2008","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.nbd.2011.08.023_bb0650","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","article-title":"Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin","volume":"8","author":"Schilling","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.08.023_bb0655","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1523\/JNEUROSCI.20-01-00219.2000","article-title":"Intraneuronal aggregate formation and cell death after viral expression of expanded polyglutamine tracts in the adult rat brain","volume":"20","author":"Senut","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.08.023_bb0660","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.1128\/MCB.00079-08","article-title":"Phosphorylation of profilin by ROCK1 regulates polyglutamine aggregation","volume":"28","author":"Shao","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.nbd.2011.08.023_bb0665","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/hmg\/8.5.763","article-title":"A Huntington's disease CAG expansion at the murine Hdh locus is unstable and associated with behavioural abnormalities in mice","volume":"8","author":"Shelbourne","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.08.023_bb0670","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.08.023_bb0675","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/sj.mt.6300049","article-title":"Enhanced survival of the LINCL mouse following CLN2 gene transfer using the rh.10 rhesus macaque-derived adeno-associated virus vector","volume":"15","author":"Sondhi","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2011.08.023_bb0680","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.nbd.2005.07.014","article-title":"Progressive phenotype and nuclear accumulation of an amino-terminal cleavage fragment in a transgenic mouse model with inducible expression of full-length mutant huntingtin","volume":"21","author":"Tanaka","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.08.023_bb0685","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/hum.2006.178","article-title":"Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain","volume":"18","author":"Taymans","year":"2007","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.nbd.2011.08.023_bb0690","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0962-8924(00)01853-5","article-title":"Huntington's disease: the challenge for cell biologists","volume":"10","author":"Tobin","year":"2000","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.nbd.2011.08.023_bb0695","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/hmg\/9.19.2799","article-title":"Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells","volume":"9","author":"Trettel","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.08.023_bb0700","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nm1239","article-title":"A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease","volume":"11","author":"Tuszynski","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2011.08.023_bb0705","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1089\/hum.2007.116","article-title":"Identification and allele-specific silencing of the mutant huntingtin allele in Huntington's disease patient-derived fibroblasts","volume":"19","author":"van Bilsen","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.nbd.2011.08.023_bb0710","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/gt.2010.179","article-title":"Efficient and stable transduction of dopaminergic neurons in rat substantia nigra by rAAV 2\/1, 2\/2, 2\/5, 2\/6.2, 2\/7, 2\/8 and 2\/9","volume":"18","author":"Van der Perren","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.nbd.2011.08.023_bb0715","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.08.023_bb0720","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington's disease","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2011.08.023_bb0725","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/j.1745-7254.2006.00410.x","article-title":"Animal models of Huntington's disease: implications in uncovering pathogenic mechanisms and developing therapies","volume":"27","author":"Wang","year":"2006","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.nbd.2011.08.023_bb0730","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/sj.gt.3302011","article-title":"Recombinant AAV serotype 1 transduction efficiency and tropism in the murine brain","volume":"10","author":"Wang","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.nbd.2011.08.023_bb0735","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/hmg\/8.1.115","article-title":"Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse","volume":"8","author":"Wheeler","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.08.023_bb0740","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1089\/hum.2010.129","article-title":"Evaluation and optimization of the administration of recombinant adeno-associated viral vectors (serotypes 2\/1, 2\/2, 2\/rh8, 2\/9, and 2\/rh10) by convection-enhanced delivery to the striatum","volume":"22","author":"White","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.nbd.2011.08.023_bb0745","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ymthe.2003.09.017","article-title":"Transduction patterns of pseudotyped lentiviral vectors in the nervous system","volume":"9","author":"Wong","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2011.08.023_bb0750","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/nm1076","article-title":"RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia","volume":"10","author":"Xia","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2011.08.023_bb0755","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","article-title":"Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease","volume":"101","author":"Yamamoto","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2011.08.023_bb0760","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/nature06975","article-title":"Towards a transgenic model of Huntington's disease in a non-human primate","volume":"453","author":"Yang","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2011.08.023_bb0765","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.nbd.2005.05.017","article-title":"Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment","volume":"20","author":"Zala","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.08.023_bb0770","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00041.2009","article-title":"Molecular mechanisms and potential therapeutical targets in Huntington's disease","volume":"90","author":"Zuccato","year":"2010","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.nbd.2011.08.023_bb0775","doi-asserted-by":"crossref","first-page":"9873","DOI":"10.1128\/JVI.72.12.9873-9880.1998","article-title":"Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery","volume":"72","author":"Zufferey","year":"1998","journal-title":"J. Virol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996111002890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996111002890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T19:28:29Z","timestamp":1592854109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996111002890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":154,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0969996111002890"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2011.08.023","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}